Ilex Capital Partners (Uk) LLP Exact Sciences Corp Transaction History
Ilex Capital Partners (Uk) LLP
- $2.45 Trillion
- Q1 2025
A detailed history of Ilex Capital Partners (Uk) LLP transactions in Exact Sciences Corp stock. As of the latest transaction made, Ilex Capital Partners (Uk) LLP holds 26,157 shares of EXAS stock, worth $1.49 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
26,157Holding current value
$1.49 Million% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding EXAS
# of Institutions
644Shares Held
157MCall Options Held
1.74MPut Options Held
1.56M-
Capital World Investors Los Angeles, CA17.8MShares$1.02 Billion0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$1 Billion0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.5MShares$712 Million0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$687 Million0.01% of portfolio
-
State Street Corp Boston, MA6.61MShares$377 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $10.1B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...